Search

everythinglearnresearchcommunity

for

Search:↓

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

The lotion with equol, dihomo-γ-linolenic acid, and propionyl-l-carnitine was effective in reducing hair loss in men and women.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Hormonal therapy is becoming a promising treatment for acne.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Topical finasteride may help treat facial hirsutism in women.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Sex hormones influence immune responses and may help treat diseases.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Some medications can help increase sexual desire and function in women.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Clinicians should be aware of alternating thyroid conditions and their treatment.